We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining

◀ Back to CXCL12

CXCL12 — CXCR5

Pathways - manually collected, often from reviews:

Text-mined interactions from Literome

Amara et al., J Biol Chem 1999 : Importantly, the amino-terminal domain of SDF-1alpha which is required for binding to, and activation of, CXCR4 remains exposed after binding to HS and is recognized by a neutralizing monoclonal antibody directed against the first residues of the chemokine
Chan et al., Ophthalmology 2003 (Lymphoma, B-Cell...) : CXCR4 and CXCR5 transcripts were detected abundantly in lymphoma cells, whereas BLC and SDF-1 transcripts were detected only in the RPE and not the malignant cells
Hu et al., Circulation 2007 (Anoxia...) : In isolated myocytes, CXCR4 activation by SDF-1alpha resulted in increased phosphorylation of both ERK 1/2 and AKT and decreased phosphorylation of JNK and p38
Sierro et al., Proc Natl Acad Sci U S A 2007 : CXCL12 did not induce signaling through CXCR7 ; however, CXCR7 formed functional heterodimers with CXCR4 and enhanced CXCL12 induced signaling
Pandruvada et al., Int J Cancer 2010 (Carcinoma, Squamous Cell...) : Interestingly, CXCL13 treatment to OSCC cells induced CXCR5 and MMP-9 expression suggesting an autocrine regulatory function in OSCC cells
Duda et al., Clin Cancer Res 2011 (Neoplasms) : CXCL12 ( SDF1alpha ) -CXCR4/CXCR7 pathway inhibition : an emerging sensitizer for anticancer therapies ?
Mueller et al., PloS one 2013 (Immunologic Deficiency Syndromes...) : Upon stimulation by the endogenous ligand CXCL12 , CXCR4 becomes phosphorylated at multiple sites in its C-terminal domain